141 related articles for article (PubMed ID: 37325241)
1. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
[TBL] [Abstract][Full Text] [Related]
2. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
[TBL] [Abstract][Full Text] [Related]
3. Promoting reproductive options for HIV-affected couples in sub-Saharan Africa.
Mmeje O; Cohen CR; Murage A; Ong'ech J; Kiarie J; van der Poel S
BJOG; 2014 Oct; 121 Suppl 5(0 5):79-86. PubMed ID: 25335844
[TBL] [Abstract][Full Text] [Related]
4. Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy.
Dohadwala S; Geib MT; Politch JA; Anderson DJ
Front Reprod Health; 2023; 5():1337479. PubMed ID: 38264184
[TBL] [Abstract][Full Text] [Related]
5. Developing multipurpose reproductive health technologies: an integrated strategy.
Harrison PF; Hemmerling A; Romano J; Whaley KJ; Young Holt B
AIDS Res Treat; 2013; 2013():790154. PubMed ID: 23533733
[TBL] [Abstract][Full Text] [Related]
6. Turning the promise of multipurpose prevention technologies into a market reality: a commentary.
Dam A; Schueller J; Peine KJ; Mason J; Dorward E; Vij A
Front Reprod Health; 2023; 5():1181043. PubMed ID: 38023534
[TBL] [Abstract][Full Text] [Related]
7. Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy.
Cohen JA; Mastroianni AC; Macklin R
Int J Gynaecol Obstet; 2014 Nov; 127(2):221-4. PubMed ID: 25113651
[TBL] [Abstract][Full Text] [Related]
8. Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy.
Young IC; Benhabbour SR
Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372059
[TBL] [Abstract][Full Text] [Related]
9. Common ground: the opportunity of male contraceptives as MPTs.
Vahdat HL; Nickels LM
Front Reprod Health; 2023; 5():1278709. PubMed ID: 38023532
[TBL] [Abstract][Full Text] [Related]
10. The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development.
Chapman K; Torres-Rueda S; Metzler M; Young Holt B; Kahn-Woods E; Thornton D; Gomez GB
Front Reprod Health; 2024; 6():1272950. PubMed ID: 38699591
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Multipurpose prevention technologies: call for innovative strategies to address critical priorities and gaps.
Soh C; van der Straten A; Hemmerling A; Turpin JA; Young Holt B
Front Reprod Health; 2024; 6():1417974. PubMed ID: 38827819
[No Abstract] [Full Text] [Related]
12. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.
Henderson AC; Cholli P; Lampe MA; Kourtis AP
Expert Rev Anti Infect Ther; 2024 Apr; 22(4):153-167. PubMed ID: 38517686
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Multipurpose prevention technologies for HIV, STIs and pregnancies.
Friedland BA; Thurman AR; Nuwagaba-Biribonwoha H; Malcolm RK
Front Reprod Health; 2024; 6():1384153. PubMed ID: 38476596
[No Abstract] [Full Text] [Related]
14. Pharmacokinetic Study of Islatravir and Etonogestrel Implants in Macaques.
Daly MB; Wong-Sam A; Li L; Krovi A; Gatto GJ; Norton C; Luecke EH; Mrotz V; Forero C; Cottrell ML; Schauer AP; Gary J; Nascimento-Seixas J; Mitchell J; van der Straten A; Heneine W; García-Lerma JG; Dobard CW; Johnson LM
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140017
[TBL] [Abstract][Full Text] [Related]
15. How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.
Nyagah W; Segal K; Feltham J; Ash A; Major J; Masani M
Front Reprod Health; 2023; 5():1254953. PubMed ID: 38023531
[TBL] [Abstract][Full Text] [Related]
16. Trends, Projections, and Regional Disparities of Maternal Mortality in Africa (1990-2030): An ARIMA Forecasting Approach.
Onambele L; Guillen-Aguinaga S; Guillen-Aguinaga L; Ortega-Leon W; Montejo R; Alas-Brun R; Aguinaga-Ontoso E; Aguinaga-Ontoso I; Guillen-Grima F
Epidemiologia (Basel); 2023 Aug; 4(3):322-351. PubMed ID: 37754279
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.
Bershteyn A; Resar D; Kim HY; Platais I; Mullick S
Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
